Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS‐CoV‐2‐specific humoral and cellular immunity persists through 9 months irrespective of COVID‐19 severity at hospitalisation
John Tyler Sandberg, Renata Varnaitė, Wanda Christ, et al.
Clinical & Translational Immunology (2021) Vol. 10, Iss. 7
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Neonates and COVID-19: state of the art
Lucy Ryan, Frans B. Plötz, Agnes van den Hoogen, et al.
Pediatric Research (2021) Vol. 91, Iss. 2, pp. 432-439
Open Access | Times Cited: 70
Role of the humoral immune response during COVID-19: guilty or not guilty?
Melyssa Yaugel-Novoa, Thomas Bourlet, Stéphane Paul
Mucosal Immunology (2022) Vol. 15, Iss. 6, pp. 1170-1180
Open Access | Times Cited: 38
Targeted plasma proteomics reveals signatures discriminating COVID-19 from sepsis with pneumonia
Laura M. Palma Medina, Haris Babačić, Majda Dzidic, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 23
Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion
Alessio Mazzoni, Lorenzo Salvati, Laura Maggi, et al.
Seminars in Immunology (2021) Vol. 55, pp. 101508-101508
Open Access | Times Cited: 53
Neutralizing Antibodies and Cellular Immune Responses Against SARS-CoV-2 Sustained One and a Half Years After Natural Infection
Lina Yan, Panpan Liu, Xu-gui Li, et al.
Frontiers in Microbiology (2022) Vol. 12
Open Access | Times Cited: 29
Seroconversion and dynamics of IgG anti-SARS-CoV-2 antibodies during the pandemic: A two-month observation cohort study on the population of Sleman in Indonesia
Jajah Fachiroh, Septi Kurnia Lestari, Dewi Kartikawati Paramita, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0316360-e0316360
Open Access
Production and persistence of specific antibodies in COVID-19 patients with hematologic malignancies: role of rituximab
Chiara Cattaneo, Valeria Cancelli, Luisa Imberti, et al.
Blood Cancer Journal (2021) Vol. 11, Iss. 9
Open Access | Times Cited: 38
SARS-CoV-2 antibody and T cell responses one year after COVID-19 and the booster effect of vaccination: A prospective cohort study
Willem A. Mak, Johannes G.M. Koeleman, Marijke van der Vliet, et al.
Journal of Infection (2021) Vol. 84, Iss. 2, pp. 171-178
Open Access | Times Cited: 33
Clinical Performance of a Standardized Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Interferon-γ Release Assay for Simple Detection of T-Cell Responses After Infection or Vaccination
Marta Fernández‐González, Vanesa Agulló, Sergio Padilla, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e338-e346
Open Access | Times Cited: 32
T follicular helper cells in the humoral immune response to SARS-CoV-2 infection and vaccination
Marios Koutsakos, Wen Shi Lee, Adam K. Wheatley, et al.
Journal of Leukocyte Biology (2021) Vol. 111, Iss. 2, pp. 355-365
Open Access | Times Cited: 32
Considerations for Novel COVID-19 Mucosal Vaccine Development
Wael Alturaiki
Vaccines (2022) Vol. 10, Iss. 8, pp. 1173-1173
Open Access | Times Cited: 20
Antibody Levels Poorly Reflect on the Frequency of Memory B Cells Generated following SARS-CoV-2, Seasonal Influenza, or EBV Infection
Carla Wolf, Sebastian Köppert, Noémi Becza, et al.
Cells (2022) Vol. 11, Iss. 22, pp. 3662-3662
Open Access | Times Cited: 19
SARS-CoV-2 spike-specific memory B cells express higher levels of T-bet and FcRL5 after non-severe COVID-19 as compared to severe disease
Raphael A. Reyes, Kathleen Clarke, S. Jake Gonzales, et al.
PLoS ONE (2021) Vol. 16, Iss. 12, pp. e0261656-e0261656
Open Access | Times Cited: 26
The (apparent) antibody paradox in COVID-19
Rohan Ameratunga, See‐Tarn Woon, Edward Lea, et al.
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 4, pp. 335-345
Open Access | Times Cited: 15
Long-Term, CD4+ Memory T Cell Response to SARS-CoV-2
Sebastian Wirsching, Laura Harder, Markus Heymanns, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Long-Lasting Immunity Against SARS-CoV-2: Dream or Reality?
Daniel Gussarow, Agnes Bonifacius, Anne Cossmann, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 18
Severe COVID-19 is a T cell immune dysregulatory disorder triggered by SARS-CoV-2
Rohan Ameratunga, See‐Tarn Woon, Richard Steele, et al.
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 6, pp. 557-565
Closed Access | Times Cited: 13
Mucosal immune responses in the lung during respiratory infection: The organization and regulation of iBALT structure
Xintong Gao, Cui Hua Liu, Shuo Wang
hLife (2023) Vol. 1, Iss. 2, pp. 71-82
Open Access | Times Cited: 6
Lower SARS-CoV-2–specific humoral immunity in people living with HIV-1 recovered from nonhospitalized COVID-19
Daniel J. Schuster, Shelly Karuna, Caroline Brackett, et al.
JCI Insight (2022) Vol. 7, Iss. 21
Open Access | Times Cited: 10
Comparable cellular and humoral immunity upon homologous and heterologous COVID-19 vaccination regimens in kidney transplant recipients
Nina Körber, Christopher Holzmann‐Littig, Gesa Wilkens, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Characterization of SARS-CoV-2 Convalescent Patients’ Serological Repertoire Reveals High Prevalence of Iso–RBD Antibodies
Nicholas C. Curtis, Seungmin Shin, Andrew P. Hederman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
T follicular helper cells and their impact on humoral responses during pathogen and vaccine challenge
Jennifer A. Juno, Danika L. Hill
Current Opinion in Immunology (2021) Vol. 74, pp. 112-117
Open Access | Times Cited: 9
Effector-Memory B-Lymphocytes and Follicular Helper T-Lymphocytes as Central Players in the Immune Response in Vaccinated and Nonvaccinated Populations against SARS-CoV-2
Lorenzo Islas-Vázquez, Marisa Cruz‐Aguilar, Henry Velázquez-Soto, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1761-1761
Open Access | Times Cited: 6
Potency assessment of IFNγ-producing SARS-CoV-2-specific T cells from COVID-19 convalescent subjects
Rubén Gil-Bescós, Ainhoa Ostiz, Saioa Zalba, et al.
Life Science Alliance (2023) Vol. 6, Iss. 6, pp. e202201759-e202201759
Open Access | Times Cited: 3
Highly Networked SARS-CoV-2 Peptides Elicit T Cell Responses with Enhanced Specificity
Gabriel Duette, Eunok Lee, Gabriela Martins Costa Gomes, et al.
ImmunoHorizons (2023) Vol. 7, Iss. 6, pp. 508-527
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top